Director, Translational Imaging Lead

Bayer•Cambridge, MA

About The Position

The Director, Translation Imaging Lead independently drives the development of strategic guidance for biomarker imaging on one or more program(s) and works towards drug development deliverables. In this role, you will primarily focus on ensuring that oncology programs are using appropriate imaging techniques from early clinical through registration phases of development, which entails directly working with cross functional teams within the drug development process. The Director of Translation Imaging will enable preclinical and clinical teams by scouting and incorporating state-of-the-art imaging strategies and suggesting (emerging) imaging approaches and techniques that will aid the development of new drugs, with a particular focus on radioligand therapies.

Requirements

Medical Doctor (MD or MD/PhD) or imaging scientist (PhD) trained in radiology, nuclear medicine, imaging physics or image analysis including some industry experience, OR b) a Master's degree trained in radiology, nuclear medicine, imaging physics or image analysis including industry experience in Clinical Imaging OR c) a Bachelors’ degree trained in radiology, nuclear medicine, imaging physics or image analysis including significant industry experience
Proven track record of research and/or development (including oncology applications with emphasis on radiological and /or PET/SPECT imaging and biomarker use) with a focus on radiopharmaceuticals
Experience with clinical and preclinical imaging in oncology drug development (PET, SPECT, CT, bioluminescence, MRI…)
Thorough understanding of imaging and clinical development in oncology; including experience with regulatory framework for biomarkers, and use of imaging for registration of Oncology products. Experience managing imaging CROs
Outstanding scientific reputation as evidenced by multiple publications in peer-reviewed journals and as speaker of conferences and strong network in the academic and clinical community of imaging specialties (mandatory) and of Oncology (preferred)
Excellent interpersonal and communication skills.

Nice To Haves

Medical doctor (MD or MD/PhD) or imaging scientist (PhD) trained in radiology, nuclear medicine, imaging physics or image analysis including a minimum of 7 years industry experience, OR a Masters’ degree trained in radiology, nuclear medicine, imaging physics or image analysis including a minimum of 9 years industry experience OR a Bachelors’ degree trained in radiology, nuclear medicine, imaging physics or image analysis including a minimum of 11 years industry experience

Responsibilities

Drive the development of strategic guidance for biomarker imaging, ensuring oncology programs utilize appropriate imaging techniques throughout the drug development process
Advise on the use of imaging biomarkers and techniques in clinical trials, focusing on radiopharmaceuticals in collaboration with Radiology and external imaging CROs
Participate in Program Teams, providing oncology expertise to develop translation and imaging strategies
Direct the global oncology Radiomics approach, providing expertise and leadership across the portfolio
Coordinate all aspects of imaging delivery in synchronization with the drug R&D process, informed by a deep understanding of clinical development in oncology and state-of-the-art imaging strategies
Develop imaging tools to measure drug response/effectiveness through internal and external collaborations
Ensure regulatory compliance of imaging activities and drive qualification processes
Evaluate, interpret, and present results from imaging analyses to support decision-making
Identify new collaboration opportunities and manage relationships with partners to drive imaging excellence
Contribute to self-empowered matrix teams, fostering a culture of creativity and innovation, and promoting a high-performance environment.